Package 0378-4050-91

{"route": ["ORAL"], "spl_id": "af4a1dc3-d150-42dc-95ab-89d579f1725a", "openfda": {"nui": ["N0000175463", "N0000175460", "N0000009948", "N0000190118", "N0000187064"], "upc": ["0303784050910"], "unii": ["99DK7FVK1H"], "rxcui": ["199422"], "spl_set_id": ["c6e93829-7024-48f6-8023-da6ff27dfc0a"], "pharm_class_epc": ["Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE, PLASTIC (0378-4050-91)", "package_ndc": "0378-4050-91", "marketing_start_date": "20120522"}], "brand_name": "Nevirapine", "product_id": "0378-4050_af4a1dc3-d150-42dc-95ab-89d579f1725a", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Non-Nucleoside Analog [EXT]", "Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "0378-4050", "generic_name": "nevirapine", "labeler_name": "Mylan Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Nevirapine", "active_ingredients": [{"name": "NEVIRAPINE", "strength": "200 mg/1"}], "application_number": "ANDA202523", "marketing_category": "ANDA", "marketing_start_date": "20120522", "listing_expiration_date": "20261231"}